Author

Mark Janicki

Observed name: Mark J. Janicki

Institutions: Cleveland Clinic, Medical University of Lodz, Alexion Pharmaceuticals (United States), St. Josef-Hospital, Ruhr University Bochum

Observed institutions: Cleveland Clinic, Medical University of Lodz, Alexion Pharmaceuticals (United States), St. Josef-Hospital, Ruhr University Bochum

OpenAlex ID: A5020580968

Characterizing absolute lymphocyte count profiles in dimethyl fumarate–treated patients with MS

2016 · Robert J. Fox, Andrew Chan, et al. · Neurology Clinical Practice · 104

Effects of delayed-release dimethyl fumarate on MRI measures in the phase 3 CONFIRM study

2015 · David H. Miller, Robert J. Fox, et al. · Neurology · 65

Intra-Arterial Thrombolysis as an Ideal Treatment for Inflammatory Bowel Disease Related Thromboembolic Stroke: A Case Report and Review

2012 · Jared R. Brosch, Mark J. Janicki · International Journal of Neuroscience · 3

Works count: 3

Citation count: 172

H-index: 3

I10-index: 2